Skip to main content
Premium Trial:

Request an Annual Quote

Not Too Bad

The biotech sector in four established areas — the US, Europe, Canada, and Australia — performed well financially in 2011, says a new report from Ernst & Young. However, Reuters adds that smaller companies are having a hard time finding funding. "The revenue growth of public companies in the four established clusters returned to double-digit territory for the first time since the advent of the [financial] crisis," the report says, adding that "while this is still a far cry from the high double-digit growth rates the industry delivered through much of the last decade, companies are also operating in a new reality now, with more cautious regulators and increased pricing pressure from payers." Spending, which Reuters notes is a sign of companies' confidence in the future, rose 9 percent in 2011, though companies' net income fell 5 percent, which may be due to higher spending after cost-cutting in 2009 and 2010.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.